South Korea
· Delayed Price · Currency is KRW Aminologics Co.,Ltd. Statistics
Total Valuation
Aminologics Co.,Ltd. has a market cap or net worth of KRW 82.03 billion. The enterprise value is 49.27 billion.
| Market Cap | 82.03B |
| Enterprise Value | 49.27B |
Important Dates
The next estimated earnings date is Friday, March 21, 2025.
| Earnings Date | Mar 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Aminologics Co.,Ltd. has 87.83 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 87.83M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | 0.31% |
| Float | 59.89M |
Valuation Ratios
The trailing PE ratio is 44.18.
| PE Ratio | 44.18 |
| Forward PE | n/a |
| PS Ratio | 3.93 |
| PB Ratio | 1.50 |
| P/TBV Ratio | 1.62 |
| P/FCF Ratio | 13.97 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 26.53 |
| EV / Sales | 2.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 8.39 |
Financial Position
The company has a current ratio of 16.39, with a Debt / Equity ratio of 0.04.
| Current Ratio | 16.39 |
| Quick Ratio | 14.02 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 18.66 |
| Debt / FCF | 0.35 |
| Interest Coverage | -4.43 |
Financial Efficiency
Return on equity (ROE) is 3.47% and return on invested capital (ROIC) is -0.39%.
| Return on Equity (ROE) | 3.47% |
| Return on Assets (ROA) | -0.37% |
| Return on Capital (ROIC) | -0.39% |
| Revenue Per Employee | 549.62M |
| Profits Per Employee | 48.87M |
| Employee Count | 38 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.87 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.97% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -31.97% |
| 50-Day Moving Average | 1,071.62 |
| 200-Day Moving Average | 1,308.75 |
| Relative Strength Index (RSI) | 38.38 |
| Average Volume (20 Days) | 188,291 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aminologics Co.,Ltd. had revenue of KRW 20.89 billion and earned 1.86 billion in profits. Earnings per share was 21.14.
| Revenue | 20.89B |
| Gross Profit | 5.85B |
| Operating Income | -342.56M |
| Pretax Income | 1.77B |
| Net Income | 1.86B |
| EBITDA | 111.18M |
| EBIT | -342.56M |
| Earnings Per Share (EPS) | 21.14 |
Balance Sheet
The company has 34.83 billion in cash and 2.07 billion in debt, giving a net cash position of 32.76 billion or 372.98 per share.
| Cash & Cash Equivalents | 34.83B |
| Total Debt | 2.07B |
| Net Cash | 32.76B |
| Net Cash Per Share | 372.98 |
| Equity (Book Value) | 54.63B |
| Book Value Per Share | 622.05 |
| Working Capital | 41.84B |
Cash Flow
In the last 12 months, operating cash flow was 6.15 billion and capital expenditures -278.00 million, giving a free cash flow of 5.87 billion.
| Operating Cash Flow | 6.15B |
| Capital Expenditures | -278.00M |
| Free Cash Flow | 5.87B |
| FCF Per Share | 66.84 |
Margins
Gross margin is 27.99%, with operating and profit margins of -1.64% and 8.89%.
| Gross Margin | 27.99% |
| Operating Margin | -1.64% |
| Pretax Margin | 8.48% |
| Profit Margin | 8.89% |
| EBITDA Margin | 0.53% |
| EBIT Margin | -1.64% |
| FCF Margin | 28.11% |
Dividends & Yields
Aminologics Co.,Ltd. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 2.26% |
| FCF Yield | 7.16% |
Stock Splits
The last stock split was on October 23, 2009. It was a forward split with a ratio of 5.
| Last Split Date | Oct 23, 2009 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
Aminologics Co.,Ltd. has an Altman Z-Score of 20.39.
| Altman Z-Score | 20.39 |
| Piotroski F-Score | n/a |